Reported Oct 29, 2025 · Ongoing
Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx…
Aspiro Pharma Limited
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aspiro Pharma Limited · Survey No. 321, Biotech Park, Phase Iii · Siddipet (District) · N/A
Is this the product you have?
- Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd
- forCamber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd
- byASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S
- Contact Number
1-866-495-1995NDC 31722-307-25 (Carton)31722-307-02 (Vial label)
- Lot codes and dates
Lot #: AS1240347AExp Date 09/2026AS1240144AExp Date 05/2026AS1240145AAS1240146AExp Date 06/2026AS1250295AExp Date 05/2027
Where it was sold
- Nationwide
Why it was recalled
Presence of Particulate Matter: Particulate matter identified as glass
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aspiro Pharma Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.